2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

Procedures represented in these studies included laparoscopic-assisted transgastric endoscopic retrograde cholangiopancreatography (LAERCP) (n = 26 studies, 381 patients), endoscopic ultrasound (EUS)-directed transgastric ERCP (EDGE) (n = 5 studies, 81 patients), laparoscopic common bile duct exploration (LCBDE) (n = 3 studies, 37 patients), balloon-assisted endoscopy (BAE) (n = 3 studies, 34 patients), intragastric single-port ERCP (IGS ERCP) (n = 2 studies, 14 patients), EUS-guided intrahepatic puncture with antegrade clearance (EGHAC) (n = 2 studies, 12 patients) and rendezvous guidewire-assisted ERCP (n = 1 study, 7 patients). Results Patient interviews revealed 4 overarching themes: (1) patients have limited knowledge about symptoms of sexual dysfunction, (2) patients receive inadequate information from the medical team regarding sexual dysfunction, (3) patients want to receive information about sexual dysfunction in different formats, (4) before the start of treatment. After a median follow-up of 51.6 (24.0-90.0) months, 592 (26.9%) patients had a clinical encounter for a bowel symptom, and 690 (31.4%) patients received a bowel medication prescription; 217 patients (31.4% of medicated patients, or 9.9% of the entire cohort) received 10 or more prescriptions. Results Among 488 patients who underwent lung surgery (wedge resection n = 100, segmentectomy n = 51, lobectomy n = 310, bilobectomy n = 10, or pneumonectomy n = 17) for either primary (n = 440) or secondary (n = 48) lung cancers, 179 (36.7%) patients had no AEs, 264 (54.1%) patients had 1 or more minor AEs and 45 (9.2%) patients had 1 or more major AEs. [Extracted from the article]